Children's Hospital Boston

Alzheimer's disease & dementia

Another angle on Alzheimer's: CSF, proteomics, and metabolic enzymes

Currently there are no objective, easily assessed diagnostic markers for Alzheimer's disease, and no good therapeutic options. Taking an agnostic approach, proteomics expert Hanno Steen, Ph.D., and neurobiologist Judith Steen, ...

Medical research

A new immune pathway sheds light on amyotrophic lateral sclerosis

While drugs are on the market to slow the progression of neurodegenerative diseases, there are still no cures. But researchers at Boston Children's Hospital and Harvard Medical School are looking for new pathways for slowing ...

page 4 from 40